APA

Krachmarov C. P., Honnen W. J., Kayman S. C., Gorny M. K., Zolla-Pazner S. & Pinter A. (20060830). Factors determining the breadth and potency of neutralization by V3-specific human monoclonal antibodies derived from subjects infected with clade A or clade B strains of human immunodeficiency virus type 1. : Journal of virology.

Chicago

Krachmarov C P, Honnen W J, Kayman S C, Gorny M K, Zolla-Pazner S and Pinter Abraham. 20060830. Factors determining the breadth and potency of neutralization by V3-specific human monoclonal antibodies derived from subjects infected with clade A or clade B strains of human immunodeficiency virus type 1. : Journal of virology.

Harvard

Krachmarov C. P., Honnen W. J., Kayman S. C., Gorny M. K., Zolla-Pazner S. and Pinter A. (20060830). Factors determining the breadth and potency of neutralization by V3-specific human monoclonal antibodies derived from subjects infected with clade A or clade B strains of human immunodeficiency virus type 1. : Journal of virology.

MLA

Krachmarov C P, Honnen W J, Kayman S C, Gorny M K, Zolla-Pazner S and Pinter Abraham. Factors determining the breadth and potency of neutralization by V3-specific human monoclonal antibodies derived from subjects infected with clade A or clade B strains of human immunodeficiency virus type 1. : Journal of virology. 20060830.